"As appetite shrinks after consuming these medications, the quality, not just quantity, of food becomes paramount, with consumers gravitating toward high-protein, fibre-rich and functional foods that support energy and muscle retention." Mediratta is former managing director at Metro AG
In the SURMOUNT-OSA trial, patients with obesity and moderate-to-severe OSA received either once-weekly tirzepatide or placebo for 52 weeks
Monday, 03 November 2025 09:30 PM Ro Weight Loss: Step-by-Step Guide to FDA-Approved GLP-1 Treatments Including Wegovy, Ozempic, and Zepbound Monday, 03 November 2025 09:30 PM Advertorial Learn how Ro's doctor-supervised GLP-1 program helps eligible adults access FDA-approved treatments like Wegovy, Ozempic, and Zepbound safely online
Question : How do I enroll into a Medicare Part D plan
In India, it is approved only for type 2 diabetes, not weight loss
Clinical Evidence on GLP-1 and Oral Contraceptive Interactions Large randomized trials of semaglutide (STEP trials) and tirzepatide (SURMOUNT trials) did not formally measure contraceptive failure rates, because most participants were not actively using hormonal birth control